LXRX logo

Lexicon Pharmaceuticals, Inc. (LXRX) CAPEX

Annual CAPEX:

$1.03M+$561.00K(+119.36%)
December 31, 2024

Summary

  • As of today, LXRX annual capital expenditures is $1.03 million, with the most recent change of +$561.00 thousand (+119.36%) on December 31, 2024.
  • During the last 3 years, LXRX annual CAPEX has fallen by -$190.00 thousand (-15.56%).
  • LXRX annual CAPEX is now -94.78% below its all-time high of $19.77 million, reached on December 31, 2002.

Performance

LXRX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXcash flow metrics

Quarterly CAPEX:

$0.00$0.00(0.00%)
September 30, 2025

Summary

  • As of today, LXRX quarterly capital expenditures is $0.00, unchanged on September 30, 2025.
  • Over the past year, LXRX quarterly CAPEX has dropped by -$307.00 thousand (-100.00%).
  • LXRX quarterly CAPEX is now -100.00% below its all-time high of $8.73 million, reached on March 31, 2002.

Performance

LXRX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXcash flow metrics

TTM CAPEX:

$474.00K-$307.00K(-39.31%)
September 30, 2025

Summary

  • As of today, LXRX TTM capital expenditures is $474.00 thousand, with the most recent change of -$307.00 thousand (-39.31%) on September 30, 2025.
  • Over the past year, LXRX TTM CAPEX has dropped by -$83.00 thousand (-14.90%).
  • LXRX TTM CAPEX is now -97.86% below its all-time high of $22.11 million, reached on June 30, 2002.

Performance

LXRX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXcash flow metrics

LXRX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+119.4%-100.0%-14.9%
3Y3 Years-15.6%-100.0%+360.2%
5Y5 Years+1372.9%-100.0%+1336.4%

LXRX CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-22.3%+119.4%-100.0%at low-72.4%+360.2%
5Y5-Year-22.3%+1372.9%-100.0%at low-72.4%+1336.4%
All-TimeAll-Time-94.8%+1372.9%-100.0%at low-97.9%>+9999.0%

LXRX CAPEX History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(0.0%)
$474.00K(-39.3%)
Jun 2025
-
$0.00(0.0%)
$781.00K(-24.2%)
Mar 2025
-
$0.00(-100.0%)
$1.03M(0.0%)
Dec 2024
$1.03M(+119.4%)
$474.00K(+54.4%)
$1.03M(+85.1%)
Sep 2024
-
$307.00K(+22.8%)
$557.00K(+67.3%)
Jun 2024
-
$250.00K(>+9900.0%)
$333.00K(+50.0%)
Mar 2024
-
$0.00(0.0%)
$222.00K(-52.8%)
Dec 2023
$470.00K(-64.6%)
$0.00(-100.0%)
$470.00K(-72.6%)
Sep 2023
-
$83.00K(-40.3%)
$1.72M(+4.8%)
Jun 2023
-
$139.00K(-44.0%)
$1.64M(+9.3%)
Mar 2023
-
$248.00K(-80.1%)
$1.50M(+13.0%)
Dec 2022
$1.33M(+8.6%)
$1.25M(>+9900.0%)
$1.33M(+1187.4%)
Sep 2022
-
$4000.00(>+9900.0%)
$103.00K(-67.0%)
Jun 2022
-
$0.00(-100.0%)
$312.00K(-75.2%)
Mar 2022
-
$76.00K(+230.4%)
$1.26M(+3.1%)
Dec 2021
$1.22M(+1303.4%)
$23.00K(-89.2%)
$1.22M(-2.5%)
Sep 2021
-
$213.00K(-77.5%)
$1.25M(+16.8%)
Jun 2021
-
$947.00K(+2392.1%)
$1.07M(+757.6%)
Mar 2021
-
$38.00K(-29.6%)
$125.00K(+43.7%)
Dec 2020
$87.00K(+24.3%)
$54.00K(+63.6%)
$87.00K(+163.6%)
Sep 2020
-
$33.00K(>+9900.0%)
$33.00K(>+9900.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2019
$70.00K(-26.3%)
$0.00(0.0%)
$70.00K(-34.6%)
Sep 2019
-
$0.00(0.0%)
$107.00K(-2.7%)
Jun 2019
-
$0.00(-100.0%)
$110.00K(-12.0%)
Mar 2019
-
$70.00K(+89.2%)
$125.00K(+31.6%)
Dec 2018
$95.00K(-58.3%)
$37.00K(+1133.3%)
$95.00K(+53.2%)
Sep 2018
-
$3000.00(-80.0%)
$62.00K(-48.3%)
Jun 2018
-
$15.00K(-62.5%)
$120.00K(-31.8%)
Mar 2018
-
$40.00K(+900.0%)
$176.00K(-22.8%)
Dec 2017
$228.00K(-1.3%)
$4000.00(-93.4%)
$228.00K(-38.7%)
Sep 2017
-
$61.00K(-14.1%)
$372.00K(+13.8%)
Jun 2017
-
$71.00K(-22.8%)
$327.00K(+21.6%)
Mar 2017
-
$92.00K(-37.8%)
$269.00K(+16.5%)
Dec 2016
$231.00K(-74.6%)
$148.00K(+825.0%)
$231.00K(+178.3%)
Sep 2016
-
$16.00K(+23.1%)
$83.00K(-66.9%)
Jun 2016
-
$13.00K(-75.9%)
$251.00K(-64.2%)
Mar 2016
-
$54.00K(-70.7%)
$701.00K(+0.4%)
Dec 2015
$910.00K(+1037.5%)
-
-
Sep 2015
-
$184.00K(-60.3%)
$698.00K(+34.0%)
Jun 2015
-
$463.00K(+2623.5%)
$521.00K(+655.1%)
Mar 2015
-
$17.00K(-50.0%)
$69.00K(-13.8%)
Dec 2014
$80.00K(-95.4%)
$34.00K(+385.7%)
$80.00K(-69.3%)
Sep 2014
-
$7000.00(-36.4%)
$261.00K(-50.0%)
Jun 2014
-
$11.00K(-60.7%)
$522.00K(-42.6%)
Mar 2014
-
$28.00K(-87.0%)
$910.00K(-47.1%)
Dec 2013
$1.72M(+249.8%)
$215.00K(-19.8%)
$1.72M(+6.3%)
Sep 2013
-
$268.00K(-32.8%)
$1.62M(+15.6%)
Jun 2013
-
$399.00K(-52.4%)
$1.40M(+27.7%)
Mar 2013
-
$839.00K(+642.5%)
$1.10M(+123.0%)
Dec 2012
$492.00K
$113.00K(+126.0%)
$492.00K(-16.3%)
Sep 2012
-
$50.00K(-47.4%)
$588.00K(-18.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
$95.00K(-59.4%)
$720.00K(-22.8%)
Mar 2012
-
$234.00K(+12.0%)
$933.00K(-22.6%)
Dec 2011
$1.21M(+6.5%)
$209.00K(+14.8%)
$1.21M(-3.6%)
Sep 2011
-
$182.00K(-40.9%)
$1.25M(-9.7%)
Jun 2011
-
$308.00K(-39.3%)
$1.39M(+20.0%)
Mar 2011
-
$507.00K(+99.6%)
$1.15M(+1.9%)
Dec 2010
$1.13M(+206.8%)
$254.00K(-19.6%)
$1.13M(+28.9%)
Sep 2010
-
$316.00K(+310.4%)
$878.00K(+40.9%)
Jun 2010
-
$77.00K(-84.1%)
$623.00K(-1.4%)
Mar 2010
-
$485.00K(+695.1%)
$632.00K(-22.7%)
Dec 2009
$369.00K(-83.1%)
-
-
Sep 2009
-
$61.00K(-29.1%)
$818.00K(-20.3%)
Jun 2009
-
$86.00K(-44.9%)
$1.03M(-29.9%)
Mar 2009
-
$156.00K(-69.7%)
$1.46M(-33.1%)
Dec 2008
$2.19M(+15.1%)
$515.00K(+91.4%)
$2.19M(-3.9%)
Sep 2008
-
$269.00K(-48.7%)
$2.27M(-3.8%)
Jun 2008
-
$524.00K(-40.4%)
$2.37M(-3.9%)
Mar 2008
-
$879.00K(+45.8%)
$2.46M(+29.5%)
Dec 2007
$1.90M(-46.9%)
$603.00K(+68.0%)
$1.90M(+10.9%)
Sep 2007
-
$359.00K(-42.1%)
$1.71M(-21.3%)
Jun 2007
-
$620.00K(+95.0%)
$2.18M(-19.6%)
Mar 2007
-
$318.00K(-23.6%)
$2.71M(-24.4%)
Dec 2006
$3.58M(-68.3%)
$416.00K(-49.4%)
$3.58M(-29.2%)
Sep 2006
-
$822.00K(-28.5%)
$5.05M(-26.1%)
Jun 2006
-
$1.15M(-3.6%)
$6.84M(-26.7%)
Mar 2006
-
$1.19M(-36.9%)
$9.34M(-17.2%)
Dec 2005
$11.28M(-4.5%)
$1.89M(-27.6%)
$11.28M(-21.9%)
Sep 2005
-
$2.61M(-28.4%)
$14.45M(-3.8%)
Jun 2005
-
$3.65M(+16.4%)
$15.01M(+10.0%)
Mar 2005
-
$3.13M(-38.1%)
$13.65M(+15.6%)
Dec 2004
$11.81M(+144.8%)
$5.06M(+59.4%)
$11.81M(+50.8%)
Sep 2004
-
$3.17M(+38.7%)
$7.83M(+24.0%)
Jun 2004
-
$2.29M(+77.2%)
$6.32M(+16.4%)
Mar 2004
-
$1.29M(+19.5%)
$5.43M(+12.5%)
Dec 2003
$4.82M(-75.6%)
$1.08M(-34.8%)
$4.82M(-37.1%)
Sep 2003
-
$1.66M(+18.5%)
$7.67M(-13.1%)
Jun 2003
-
$1.40M(+102.9%)
$8.82M(-24.7%)
Mar 2003
-
$689.00K(-82.4%)
$11.72M(-40.7%)
Dec 2002
$19.77M(+46.7%)
$3.92M(+39.4%)
$19.77M(-8.6%)
Sep 2002
-
$2.81M(-34.5%)
$21.64M(-2.1%)
Jun 2002
-
$4.29M(-50.8%)
$22.11M(+12.2%)
Mar 2002
-
$8.73M(+50.8%)
$19.71M(+46.3%)
Dec 2001
$13.47M(+74.7%)
$5.79M(+76.4%)
$13.47M(+20.0%)
Sep 2001
-
$3.28M(+73.0%)
$11.22M(+4.4%)
Jun 2001
-
$1.90M(-23.9%)
$10.75M(+10.2%)
Mar 2001
-
$2.50M(-29.6%)
$9.76M(+26.5%)
Dec 2000
$7.71M(+88.0%)
$3.54M(+25.9%)
$7.71M(+85.1%)
Sep 2000
-
$2.81M(+212.9%)
$4.17M(+208.4%)
Jun 2000
-
$899.70K(+99.5%)
$1.35M(+199.5%)
Mar 2000
-
$450.90K
$450.90K
Dec 1999
$4.10M(-27.5%)
-
-
Dec 1998
$5.66M(+338.9%)
-
-
Dec 1997
$1.29M
-
-

FAQ

  • What is Lexicon Pharmaceuticals, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. annual CAPEX year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. TTM CAPEX year-on-year change?

What is Lexicon Pharmaceuticals, Inc. annual capital expenditures?

The current annual CAPEX of LXRX is $1.03M

What is the all-time high annual CAPEX for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high annual capital expenditures is $19.77M

What is Lexicon Pharmaceuticals, Inc. annual CAPEX year-on-year change?

Over the past year, LXRX annual capital expenditures has changed by +$561.00K (+119.36%)

What is Lexicon Pharmaceuticals, Inc. quarterly capital expenditures?

The current quarterly CAPEX of LXRX is $0.00

What is the all-time high quarterly CAPEX for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $8.73M

What is Lexicon Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?

Over the past year, LXRX quarterly capital expenditures has changed by -$307.00K (-100.00%)

What is Lexicon Pharmaceuticals, Inc. TTM capital expenditures?

The current TTM CAPEX of LXRX is $474.00K

What is the all-time high TTM CAPEX for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high TTM capital expenditures is $22.11M

What is Lexicon Pharmaceuticals, Inc. TTM CAPEX year-on-year change?

Over the past year, LXRX TTM capital expenditures has changed by -$83.00K (-14.90%)
On this page